Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
Request Account
External Funding Programs
The Diabetic Complications Consortium provide access to multiple funding mechanisms to enhance research activities that use the DiaComp infrastructure. These funding programs are open to the public and submissions are variable based on the program. This page provides information regarding the current funding programs available and will be updated regularly to reflect any changes or additions.
Pilot & Feasibility Program
Preclinical Testing Program
Summer Student Program
Conference Support Program
Collaborative Funding Program
External Funding Programs
Past DiaComp Funding Program Awardees
There is strong evidence that diabetic complications are linked via dysregulation of common pathways. The Diabetic Complications Consortium (DiaComp) promotes communication and collaboration between research communities investigating similar pathologic mechanisms in different organs by organizing an annual scientific meeting and funding new basic and translational research activities.
More information is available
here
Applications for the Pilot & Feasibility Funding Program are no longer being accepted.
T1D-RAID and NIH-RAID are cooperative programs designed to facilitate translation to the clinic of novel, scientifically meritorious therapeutic interventions. However, in some cases, additional preclinical testing is needed to validate potential therapies under disease-specific conditions and in multiple animal models before new therapeutics can progress along the drug development pipeline.
In recognition of the compelling need to develop new therapeutics for several diabetic complications, DiaComp has established a Preclinical Testing Program (DiaComp-PTP). The DiaComp-PTP will provide investigators with access to pilot funds to pursue additional preclinical studies of promising new therapeutics. The T1D-RAID and DiaComp-PTP are programs intended to remove the most common barriers to progress in identification and development of new therapies for complications of Type 1 Diabetes. The common goal of these programs is to support the preclinical work necessary to obtain "proof of principle" establishing that a new molecule or novel approach will be a viable candidate for expanded clinical evaluation.
More information is available
here
Submit a New Preclinical Testing Program Application for 2023
The DiaComp program partners with the NIDDK Diabetes Research Centers to support summer research experiences for first- and second-year medical students as part of the NIDDK Medical Student Research Program in Diabetes. (
http://medicalstudentdiabetesresearch.org/
) This program offers first- and second-year medical students the opportunity to conduct mentored research in diabetes and diabetic complications at one of the NIDDK-funded Diabetes Research centers. (
http://diabetescenters.org/centers
) DiaComp students also participate in a core curriculum of seminars on research approaches as well as a variety of clinical and research topics in diabetes and diabetic complications. At the conclusion of the summer, each student presents his/her work at the NIDDK Medical Student Research Program research symposium, which provides a venue for students to meet, share their research, and to learn about career pathways and opportunities in NIDDK-related professions.
Students: applications for the 2023 summer program are now CLOSED. The Summer Student Opportunities Program will re-open in late Fall 2023.
More information is available
here
Diabetic foot ulcers are the most common cause of non-traumatic lower leg amputation in the United States. Despite efforts to prevent and treat foot ulcers, each year about 70,000 Americans with diabetes will lose part of their lower extremity because a foot ulcer becomes infected or does not heal. An obstacle to the development of therapies is the paucity of validated biomarkers that assess healing, infection, and recurrence risk, and validated outcomes that measure patient satisfaction and quality of life. In addition, systematic reviews of clinical studies on the prevention and management of diabetic foot ulcers consistently point to the urgent need for clinical trials with standardized definitions, outcomes, biomarkers, and protocols that will enable a thorough evaluation of treatments and comparison of results across trials.
More information is available
here
This program supports high-quality Conferences and Scientific Meetings that feature sessions or speakers that are directly relevant to diabetic complications and promote communication and collaboration between research communities investigating similar pathologic mechanisms in different end organs of complications.
More information is available
here
The following external funding programs are currently available. Please check this page often for updates and sign-up for the DiaComp newsletter to get notified of new programs for the consortium.
External Funding Program Opportunities
Request for Information (RFI): Increasing the diversity of applications to the NIH Common Fund High-Risk, High-Reward Research Program
New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
MICROMouse: MMPC Initiative for Collaborative Research On the Mouse
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
Internet Explorer
Google Chrome
FireFox
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!